J. Chermann

发表

Synthesis and antiviral activity of new anti-HIV amprenavir bioisosteres.

L. Rocheblave, F. Bihel, C. De Michelis, 2002, Journal of medicinal chemistry.

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

J. Chermann, F. Barré-Sinoussi, F. Rey, 1983, Science.

Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1

J. Chermann, V. Zachar, B. Spire, 1991, Journal of virology.

Standardized nested polymerase chain reaction-based assay for detection of human immunodeficiency virus type 1 DNA in whole blood lysates

V. Barlet, J. Chermann, C. Bastard, 1993, Journal of clinical microbiology.

Surface CD4 density remains constant on lymphocytes of HIV-infected patients in the progression of disease.

J. Chermann, C. Tamalet, J. Sampol, 1991, Research in immunology.

Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases.

M. Fukushima, J. Chermann, F. Barré-Sinoussi, 1990, European journal of biochemistry.

Composition and antiviral activities of a sulfated polysaccharide from schizymenia dubyi (rhodophyta, gigartinales)

J. Chermann, M. Lahaye, J. Kornprobst, 1993 .

A recombinant human monoclonal anti-R7V antibody as a potential therapy for HIV infected patients in failure of HAART.

J. Chermann, C. Haslin, M. Duonor-Cérutti, 2008, Human antibodies.

ACQUIRED IMMUNODEFICIENCY SYNDROME AFTER TRAVELLING IN AFRICA: AN EPIDEMIOLOGICAL STUDY IN SEVENTEEN CAUCASIAN PATIENTS

B. Autran, J. Chermann, F. Rey, 1987, The Lancet.

Inhibition of reverse transcriptase activity by a flavonoid compound, 5,6,7-trihydroxyflavone.

M. Fukushima, J. Chermann, F. Barré-Sinoussi, 1989, Biochemical and biophysical research communications.

A common antigenic constituent in various purified Salmonella endotoxins.

J. Chermann, M. Raynaud, M. Navarro, 1973, The Journal of infectious diseases.

The env gene variability is not directly related to the high cytopathogenicity of an HIV1 variant.

J. Chermann, B. Spire, I. Hirsch, 1990, Virology.

Synthesis and Anti-HIV Evaluation of New 5-Substituted-2′,3′-Dideoxy-3′-thiauridine Nucleosides

J. Chermann, J. Kraus, M. Camplo, 1996 .

Peptide-Nucleoside Conjugates: Synthesis and Anti-HIV Activities

J. Chermann, J. Kraus, M. Camplo, 1995 .

Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity

J. Kurtzberg, J. Chermann, K. Olden, 1999, British Journal of Cancer.

Synthesis and antiviral activity of new carbonylphosphonate 2',3'-dideoxy-3'-thiacytidine conjugates.

J. Chermann, C. Trépo, M. Camplo, 1994, Antiviral research.

Differential inhibition of the activities of reverse transcriptase and various cellular DNA polymerases by a traditional Kampo drug, sho-saiko-to.

M. Fukushima, J. Chermann, F. Barré-Sinoussi, 1990, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Apoptosis of CD4+ T cells induced after contact with HIV1-infected or non-infected macrophages.

J. Chermann, C. Godard, H. Serriès, 1997, Research in virology.

SYNTHESIS AND ANTI-HIV SCREENING OF SOME HETEROCYCLIC COMPOUNDS

J. Chermann, J. Kraus, R. Verma, 1997 .

Synthesis and Biological Evaluation of a New N4-(N-Formyl Peptide)- 2′,3′-Dideoxy-3′-Thiacytidine as Anti-Hiv Prodrug

F. Lederer, J. Chermann, J. Kraus, 1993 .

Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine.

J. Chermann, C. Jasmin, M. Tovey, 1984, The Journal of general virology.

A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells.

J. Chermann, F. Barré-Sinoussi, L. Montagnier, 1986, Journal of immunology.

The effects of HIV on hematopoiesis

J. Chermann, V. Calenda, 1992, European journal of haematology.

Humoral response in rabbits immunized with calcium phosphate adjuvanted HIV-1 gp160 antigen.

J. Chermann, E. Relyveld, 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Metabolism of 5' deoxy-5'[35S]-isobutyl-thio-adenosine (SIBA) in rats and mice.

M. Robert-Gero, J. Chermann, F. Lawrence, 1980, Biochemical pharmacology.

New 3'-azido-3'-deoxythymidin-5'-yl O-(omega-hydroxyalkyl) carbonate prodrugs: synthesis and anti-HIV evaluation.

E. De Clercq, C. Pannecouque, F. Bihel, 2001, Journal of medicinal chemistry.

Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: in vitro study on bone marrow progenitor cells

J. Chermann, J. Delamarter, V. Calenda, 1994, European journal of haematology.

Human colon epithelial cells productively infected with human immunodeficiency virus show impaired differentiation and altered secretion

J. Chermann, J. Fantini, S. Baghdiguian, 1992, Journal of virology.

Surface Marker Data and Functional Analysis of Hemophilia Patients with and without Antibodies to LAV1

P. Wernet, J. Chermann, F. Barré-Sinoussi, 1986 .

ISOLATION OF NEW LYMPHOTROPIC RETROVIRUS FROM TWO SIBLINGS WITH HAEMOPHILIA B, ONE WITH AIDS

A. Fischer, C. Griscelli, J. Chermann, 1984, The Lancet.

Sexual and Mother‐to‐Child Transmission of the Human Immunodeficiency Virus Type 1: A Review

J. Chermann, 1998, American journal of reproductive immunology.

Combined chemoimmunostimulation therapy against murine leukemia.

J. Chermann, J C Chermann, J W Pearson, 1972, Cancer research.

2-l-Rhamnopyranosyl[1,2,4]triazolo[1,5-a]pyridine. 4' and 3' Oxidation products. Synthesis and structure-activity relationships.

J. Chermann, F. Barré-Sinoussi, J. Igolen, 1981, Journal of medicinal chemistry.

Antiviral and anticoagulant activities of a water-soluble fraction of the marine diatom Haslea ostrearia.

J. Chermann, S. Billaudel, J. Robert, 1999, Planta medica.

Synthesis and anti-HIV activities of symmetrical N1,N3-dibenzyl-2-hydroxy-propane derivatives.

L. Rocheblave, J. Chermann, J. Kraus, 1998, Bioorganic & medicinal chemistry letters.

Use of proline bioisosteres in potential HIV protease inhibitors: phenylalanine-2-thiophenoxy-3-pyrrolidinone: synthesis and anti-HIV evaluation.

J. Courcambeck, J. Chermann, J. Kraus, 2000, Bioorganic & medicinal chemistry letters.

Synthesis and anti-HIV evaluation of new 2′,3′- dideoxy-3′-thiacytidine prodrugs

J. Chermann, J. Kraus, M. Camplo, 2000, Nucleosides, nucleotides & nucleic acids.

Synthesis and anti-HIV activity of alpha-thiophenoxy-hydroxyethylamide derivatives.

L. Rocheblave, G. Priem, J. Chermann, 1999, European journal of medicinal chemistry.

In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate.

J. Chermann, C. Jasmin, M. Raynaud, 1974, Journal of the National Cancer Institute.

Short and unexpectedly potent 3-pyrrolidinone type inhibitors of HIV-1 replication

J. Chermann, J. Kraus, M. Camplo, 1998 .

HIV-1 protease inhibitors containing statine: inhibitory potency and antiviral activity.

J. Chermann, J. Fehrentz, D. Nisato, 1992, Biochemical and biophysical research communications.

Statine based tripeptides as potent inhibitors of HIV-1 replication.

J. Chermann, J. Fehrentz, D. Nisato, 1992, Biochemical and biophysical research communications.

In vitro study of Seraspenide on HIV‐induced inhibition of granulopoiesis

J. Chermann, C. Coutton, 1997, European journal of haematology.

FUNCTIONAL T4 HELPER CELLS IN PATIENT WITH HTLV RELATED SÉZARY SYNDROME

J. Chermann, J. Brouet, C. Grillot‐Courvalin, 1983, The Lancet.

Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases.

F. Brun-Vézinet, J. Lifson, J. Chermann, 1986, The American journal of medicine.

ISOLATION OF HUMAN T-LYMPHOTROPIC RETROVIRUS (LAV) FROM ZAIRIAN MARRIED COUPLE, ONE WITH AIDS, ONE WITH PRODROMES

F. Brun-Vézinet, J. Chermann, F. Rey, 1984, The Lancet.

DETECTION OF IgG ANTIBODIES TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN PATIENTS WITH AIDS OR LYMPHADENOPATHY SYNDROME

F. Brun-Vézinet, J. Chermann, F. Barré-Sinoussi, 1984, The Lancet.

INACTIVATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS BY HEAT, GAMMA RAYS, AND ULTRAVIOLET LIGHT

J. Chermann, F. Barré-Sinoussi, L. Montagnier, 1985, The Lancet.

INACTIVATION OF LYMPHADENOPATHY ASSOCIATED VIRUS BY CHEMICAL DISINFECTANTS

J. Chermann, F. Barré-Sinoussi, L. Montagnier, 1984, The Lancet.

Replication of primate oncornavirus SSV-1 on MRC-5 human diploid cells.

J. Chermann, M. Tardy-Panit, F. Horodniceanu, 1976, Developments in biological standardization.

ANTIBODIES TO HTLV I AND III IN SERA FROM TWO JAPANESE PATIENTS, ONE WITH POSSIBLE PRE-AIDS

J. Chermann, F. Barré-Sinoussi, RobertC. Gallo, 1984, The Lancet.

Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.

C. Griscelli, J. Chermann, F. Barré-Sinoussi, 1984, Science.

Correlation between structure of polyoxotungstates and their inhibitory activity on polymerases.

J. Chermann, C. Jasmin, M. Herve, 1983, Biochemical and biophysical research communications.

Differential inhibition of various mammalian DNA polymerase activities by ammonium 21-tungsto-9-antimoniate (HPA23).

J. Chermann, F. Barré-Sinoussi, K. Ono, 1988, European journal of biochemistry.

In vivo effect of a new mineral condensed ion (HPA 39) on murine Friend leukaemia.

N. Larnicol, J. Chermann, C. Jasmin, 1981, The Journal of general virology.

Inhibition of rabies virus in vitro by the ammonium-5-tungsto-2-antimoniate.

J. Chermann, C. Jasmin, P. Atanasiu, 1978, The Journal of general virology.

Effects of 5-tungsto-2-antimoniate in oncogenic DNA and RNA virus-cell systems.

J. Chermann, C. Jasmin, D. Twardzik, 1977, European journal of cancer.

Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice.

J. Chermann, C. Jasmin, G. Werner, 1976, The Journal of general virology.

Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate.

J. Chermann, C. Jasmin, F. Sinoussi, 1975, Biochemical and biophysical research communications.

Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.

J. Chermann, F. Barré-Sinoussi, L. Montagnier, 1984, Science.

Nucleotide sequence of HIV1-NDK: a highly cytopathic strain of the human immunodeficiency virus.

F. Galibert, J. Chermann, F. Barré-Sinoussi, 1989, Gene.

Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis.

F. Brun-Vézinet, J. Chermann, F. Barré-Sinoussi, 1985, The New England journal of medicine.

A new type of retrovirus isolated from patients presenting with lymphadenopathy and acquired immune deficiency syndrome: Structural and antigenic relatedness with equine infectious anaemia virus

J. Chermann, F. Barré-Sinoussi, F. Rey, 1984 .

Annual variation in composition andin vitro anti-HIV-1 activity of the sulfated glucuronogalactan fromSchizymenia dubyi (Rhodophyta, Gigartinales)

J. Chermann, M. Rimbert, M. Lahaye, 1996, Journal of Applied Phycology.

In vitro anti-HIV activity of sulfated cell-wall polysaccharides from gametic, carposporic and tetrasporic stages of the Mediterranean red alga Asparagopsis armata.

J. Chermann, M. Lahaye, M. Pellegrini, 2001, Planta medica.

Immunostimulating Activity of Whole Cells, Cell-Walls and Fractions of Anaerobic Corynebacteria

J. Chermann, M. Raynaud, B. Bizzini, 1974 .

Susceptibility of cultured human trophoblasts to infection with human immunodeficiency virus type 1.

J. Chermann, V. Zachar, B. Spire, 1991, The Journal of general virology.

Replication of human immunodeficiency virus type 1 in primary cultured placental cells.

J. Chermann, H. Mano, 1991, Research in virology.

Productive infection of embryonal carcinoma cells with ecotropic mouse type C viruses and subsequent arrest of differentiation.

J. Levy, J. Chermann, F. Jacob, 1982, Virology.

Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals

J. Chermann, I. Hirsch, X. Xu, 1997, Journal of virology.

Synthesis and anti-human immunodeficiency virus type 1 activities of new peptido-nucleoside analogues

J. Chermann, J. Kraus, P. Barthélémy, 1995 .

Modelisation, synthesis and antiviral evaluation of new 2,3-disubstituted thiazolidinone nucleoside analogues

F. Zoulim, J. Chermann, J. Kraus, 1996 .

Inhibition of HIV by an anti-HIV protease synthetic peptide blocks an early step of viral replication.

J. Chermann, I. Hirsch, D. Nisato, 1992, Research in virology.

Differential inhibition by an antitumoral drug 10-[gamma-diethylaminopropylamino]-6-methyl-5H-pyrido[3',4': 4,5]pyrrolo [2,3-G]isoquinoline (BD-40), a pyrido-pyrrolo-isoquinoline derivative, of in vitro DNA synthesis catalyzed by various DNA polymerases.

J. Chermann, F. Barré-Sinoussi, K. Ono, 1990, Cancer letters.

Molecular cloning of lymphadenopathy-associated virus

J. Chermann, S. Wain-Hobson, F. Barré-Sinoussi, 1984, Nature.

Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates.

J. Chermann, J. Kraus, M. Camplo, 1994, Journal of medicinal chemistry.

Inhibition of RNA-dependent DNA polymerases of AIDS and SAIDS retroviruses by HPA-23 (ammonium-21-tungsto-9-antimoniate)

J. Chermann, F. Barré-Sinoussi, L. Montagnier, 1985 .

Screening for lymphadenopathy/AIDS virus in bone marrow-transplant recipients.

J. Chermann, C. Rouzioux, L. Montagnier, 1986, The New England journal of medicine.

HIV Reverse Transcriptase (RT) and HIV Protease Inhibitors

J. Chermann, J. Kraus, M. Camplo, 1997 .

Modelization, Synthesis and Antiviral Evaluation of New 2,3‐ Disubstituted Thiazolidinone Nucleoside Analogues.

F. Zoulim, J. Chermann, J. Kraus, 1996 .

Detection and titration of neutralizing antibodies to HIV using an inhibition of the cytopathic effect of the virus on MT4 cells.

J. Chermann, F. Barré-Sinoussi, F. Rey, 1987, Journal of virological methods.

HIV as the cause of AIDS and associated diseases

J. Chermann, P. Galéa, 2004, Genetica.

Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines.

J. Chermann, F. Barré-Sinoussi, M. Nugeyre, 1984, Science.

Synthesis and antiviral activity of N-4′-dihydropyridinyl and dihydroquinolinylcarbonyl-2-hydroxymethyl-5-[cytosin-1′-yl]-1,3-oxathiolane derivatives against human immunodeficiency virus and duck hepatitis B virus

J. Chermann, J. Kraus, C. Borel, 1996 .

ANTIMONIOTUNGSTATE (HPA 23) TREATMENT OF THREE PATIENTS WITH AIDS AND ONE WITH PRODROME

C. Griscelli, J. Chermann, F. Barré-Sinoussi, 1985, The Lancet.

Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS.

F. Brun-Vézinet, P. Piot, H. Taelman, 1984, Science.

Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester.

J. Chermann, H. Mano, Jean-Claude Chermann, 1991, AIDS research and human retroviruses.

Antilymphocyte antibodies and seropositivity for retroviruses in groups at high risk for AIDS.

J. Levy, J. Chermann, R. Anderson, 1985, The New England journal of medicine.

Lectin-mediated effects on HIV type 1 infection in vitro.

J. Chermann, I. Hirsch, L. Hammar, 1995, AIDS research and human retroviruses.

Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells.

V. Georgoulias, J. Chermann, M. Nugeyre, 1989, The Journal of clinical investigation.

Effects of thymus humoral factor gamma-2 (THF gamma 2) on lymphohaematopoietic progenitor cells: an in vitro study.

J. Chermann, F. Silvy, V. Calenda, 1993, Research in immunology.

Modulation of normal human erythropoietic progenitor cells in long-term liquid cultures after HIV-1 infection.

J. Chermann, V. Calenda, G. Sébahoun, 1992, AIDS research and human retroviruses.

Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2.

V. Georgoulias, J. Chermann, M. Nugeyre, 1987, Leukemia research.

Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia.

J. Chermann, J. Gruest, L. Montagnier, 1980, Bulletin du cancer.

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.

L. Arthur, J. Chermann, J. Bess, 1992, Science.

Inactivation and Partition of Human Immunodeficiency Virus during Kistler and Nitschmann Fractionation of Human Blood Plasma 1

J. Chermann, F. Barré-Sinoussi, V. Maréchal, 1988, Vox sanguinis.

The human immunodeficiency virus (HIV) gag gene product p18 is responsible for enhanced fusogenicity and host range tropism of the highly cytopathic HIV-1-NDK strain

J. Chermann, I. Hirsch, D. Salaun, 1992, Journal of virology.

[Demonstration of an antiviral substance in the culture medium of cells of the NZB mouse].

J. Levy, J. Chermann, C. Jasmin, 1973, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles.

Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelial cells.

J. Chermann, J. Fantini, N. Yahi, 1991, Proceedings of the National Academy of Sciences of the United States of America.

HIV Tat protein potentiates in vitro granulomonocytic progenitor cell growth

J. Chermann, V. Calenda, 1995, European journal of haematology.

Risk factors for AIDS and HIV seropositivity in homosexual men.

J. Chermann, F. Barré-Sinoussi, P. Bacchetti, 1987, American journal of epidemiology.

J. Chermann, L. Montagnier, R. Lidereau, 1984, Biochemical and biophysical research communications.

Enhancement of retrovirus production by anti-interferon serum.

J. Chermann, F. Barré-Sinoussi, L. Montagnier, 1979, Annals of Microbiology.

HIV-associated diseases: acute and regressive encephalopathy in a seropositive man.

J. Chermann, Jean-Claude Chermann, 1990, Research in virology.

Anti-beta 2-microglobulin monoclonal antibodies mediate a delay in HIV1 cytopathic effect on MT4 cells.

J. Chermann, F. Rey, M. Benkirane, 1990, Research in immunology.

Role of white Cells in Reagents for AIDS

J. Chermann, F. Barré-Sinoussi, F. Rey, 1987 .

A Novel Human Lymphotropic Retrovirus (LAV): New Data on Its Biology and Role in AIDS

J. Chermann, F. Barré-Sinoussi, C. Rouzioux, 1985 .

Differential effect of methyl-isobutyl-amino-adenosine (MIBUNA) on murine leukaemia virus replication and on the cellular transformation as induced by murine sarcoma virus*

J. Chermann, F. Barré-Sinoussi, M. Robert-Géro, 1982 .

Rationale for a vaccine using cellular-derived epitope presented by HIV isolates.

J. Chermann, C. le Contel, C. Coutton, 1999, Vaccine.

Genomic variability of selected LAV-related AIDS retroviruses.

J. Chermann, F. Barré-Sinoussi, B. Spire, 1986, AIDS research.

Antiviral Activities of Sulfated Polysaccharides Isolated from Sphaerococcus coronopifolius (Rhodophytha, Gigartinales) and Boergeseniella thuyoides (Rhodophyta, Ceramiales)

J. Chermann, C. Haslin, G. Simon, 2011, Marine drugs.

Severe in vitro inhibition of erythropoiesis and transient stimulation of granulopoiesis after bone‐marrow infection with eight different HIV‐2 isolates

J. Chermann, V. Calenda, 1992, AIDS.

Sequence analysis of original HIV-1

W. Blattner, M. Reitz, J. Chermann, 1991, Nature.

Search for compounds which have an inhibitory effect on rhabdovirus multiplication In Vitro

F. Bussereau, D. Clercq, J. Chermann, 1983 .

Inhibition of human immunodeficiency virus type 1 reverse transcriptase dimerization using synthetic peptides derived from the connection domain.

R. Goody, J. Chermann, G. Divita, 1994, The Journal of biological chemistry.

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983.

J. Chermann, F. Barré-Sinoussi, F. Rey, 2004, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Distinctive pattern of infection and replication of HIV1 strains in blood-derived macrophages.

J. Chermann, H. Schmidtmayerova, I. Hirsch, 1992, Virology.

New anti-HIV derivatives: synthesis and antiviral evaluation.

L. Rocheblave, C. De Michelis, G. Priem, 2000, Bioorganic & medicinal chemistry.

Productive infection of CD4+ cells by selected HIV strains is not inhibited by anti-CD4 monoclonal antibodies.

J. Chermann, F. Rey, I. Hirsch, 1991, Virology.

HIV-I AND HIV-II DOUBLE INFECTION IN CENTRAL AFRICAN REPUBLIC

J. Chermann, F. Barré-Sinoussi, F. Rey, 1986, The Lancet.

Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome.

J. Chermann, M. Gottlieb, H. Jaffe, 1984, Science.

Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state.

F. Brun-Vézinet, J. Chermann, F. Barré-Sinoussi, 1984, The New England journal of medicine.

HIV-1 infectivity of human carcinoma cell lines lacking CD4 receptors.

J. Chermann, I. Hirsch, C. Derderian, 1992, Cancer letters.

Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside Africa.

J. Chermann, I. Hirsch, A. A. Machado, 1995, Vaccine.

HIGH PREVALENCE OF LYMPHADENOPATHY VIRUS (LAV) IN EUROPEAN HAEMOPHILIACS

R. Biggar, J. Chermann, L. Montagnier, 1984, The Lancet.

Organ distribution of reverse transcriptase and cellular DNA polymerases in Friend virus-infected mice: analysis by phosphocellulose column chromatography.

J. Chermann, F. Barré-Sinoussi, F. Rey, 1984, Cellular and molecular biology.

New HIV plaque titration; application to the assay of neutralizing antibody.

J. Chermann, Y. Tsunetsugu-Yokota, A. Naito, 1993, Journal of virological methods.

Characterization of monoclonal antibodies directed against distinct conserved epitopes of human immunodeficiency virus type 1 core proteins

J. Chermann, C. Devaux, F. Kourilsky, 1990, Molecular and Cellular Biochemistry.

Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus.

J. Chermann, F. Barré-Sinoussi, F. Rey, 1985, Virology.

INFECTION OF CHIMPANZEES WITH LYMPHADENOPATHY-ASSOCIATED VIRUS

Luc Montagnier, H. McClure, J. Chermann, 1984, The Lancet.

Structural variability ofenv andgag gene products from a highly cytopathic strain of HIV-1

J. Chermann, J. Fantini, I. Hirsch, 2005, Archives of Virology.

Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives.

J. Chermann, F. Wendling, E. Bisagni, 1980, Journal of Medicinal Chemistry.

Antitumor amino-substituted pyrido[3',4':4,5]pyrrolo[2,3-g]isoquinolines and pyrido[4,3-b]carbazole derivatives: synthesis and evaluation of compounds resulting from new side chain and heterocycle modifications.

J. Chermann, F. Wendling, E. Bisagni, 1983, Journal of medicinal chemistry.

Synthese et etude de 5H-pyrido[4,3-b]-benzo[f]indoloquinones-6,11 apparentees aux ellipticines et aux anthracyclines

J. Chermann, E. Bisagni, C. Rivalle, 1985 .

STRUCTURE-ACTIVITY RELATIONSHIPS IN A SERIES OF NEWLY SYNTHESIZED 1-AMINO-SUBSTITUTED ELLIPTICINE DERIVATIVES

J. Chermann, F. Wendling, E. Bisagni, 1981 .

Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterization.

J. Chermann, T. Tokunaga, M. Honda, 1989, Journal of immunology.

Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor.

J. Chermann, E. Gluckman, J. Gluckman, 1987, Transplantation.

An early postinfection signal mediated by monoclonal anti-beta 2 microglobulin antibody is responsible for delayed production of human immunodeficiency virus type 1 in peripheral blood mononuclear cells

J. Chermann, C. Devaux, P. Corbeau, 1990, Journal of virology.

Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus).

J. Chermann, F. Barré-Sinoussi, L. Montagnier, 1984, Biochemical and biophysical research communications.

Selected human immunodeficiency virus replicates preferentially through the basolateral surface of differentiated human colon epithelial cells.

J. Chermann, J. Fantini, S. Baghdiguian, 1991, Virology.

Characterization of monoclonal antibodies identifying type and strain-specific epitopes of human immunodeficiency virus type 1

J. Chermann, M. Resnicoff, V. Robert, 1991, Molecular and Cellular Biochemistry.

Cultured trophoblastic choriocarcinoma cells differentially express HIV-1 and cloned provirus.

J. Chermann, V. Zachar, B. Spire, 1991, AIDS.

Lymphadenopathy associated virus and its etiological role in AIDS.

F. Brun-Vézinet, J. Chermann, S. Wain-Hobson, 1984, Princess Takamatsu symposia.

Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progression.

J. Chermann, C. le Contel, J. Wijdenes, 1997, Research in immunology.

RESISTANCE OF AIDS VIRUS AT ROOM TEMPERATURE

J. Chermann, F. Barré-Sinoussi, M. Nugeyre, 1985, The Lancet.

[Study of HIV localization in sperm].

J. Chermann, F. Silvy, P. Galéa, 1997, Contraception, fertilite, sexualite.

Discrepancies in AIDS virus data

J. Chermann, N. Guettari, N. Yahi, 1991, Nature.

Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS.

F. Brun-Vézinet, J. Chermann, F. Barré-Sinoussi, 1985, JAMA.

Analysis and Immunological Properties of Lymphadenopathy Associated Virus (LAV) Structural Proteins

J. Chermann, F. Barré-Sinoussi, L. Montagnier, 1985 .

Retroviruses and AIDS

J. Chermann, F. Barré-Sinoussi, L. Montagnier, 1985 .

Lymphadenopathy associated virus (L.A.V.): its association with AIDS or prodromes.

J. Chermann, F. Barré-Sinoussi, 1985, Advances in Experimental Medicine and Biology.

Transient antibody to lymphadenopathy-associated virus/human T-lymphotropic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome.

F. Brun-Vézinet, J. Lifson, J. Chermann, 1985, Annals of internal medicine.

Seropositivity to LAV/HTLV-III in 11 European countries.

J. Chermann, M. Melbye, P. Ebbesen, 1986, European journal of cancer & clinical oncology.

HIV inactivation by a spermicide containing benzalkonium chloride

J. Chermann, F. Barré-Sinoussi, V. Maréchal, 1987 .

Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families

L. Notarangelo, A. Plebani, J. Chermann, 1986, Infection.

LYMPHADENOPATHY SYNDROME AND SEROCONVERSION TWO MONTHS AFTER SINGLE USE OF NEEDLE SHARED WITH AN AIDS PATIENT

B. Autran, J. Chermann, D. Vittecoq, 1986, The Lancet.

In vitro effects of silicotungstate on some RNA viruses.

J. Chermann, C. Jasmin, M. Raynaud, 1973, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Inactivation du «lymphadenopathy AIDS virus» (LAV)

J. Chermann, F. Barré-Sinoussi, M. Nugeyre, 1985 .

[Zonal centrifuge purification of human rabies vaccine obtained on bovine foetal kidney cells (author's transl)].

J. Chermann, P. Atanasiu, H. Tsiang, 1977, Annales de microbiologie.

Primary intestinal epithelial cells can be infected with laboratory-adapted strain HIV type 1 NDK but not with clinical primary isolates.

E. Matoušková, J. Chermann, I. Hirsch, 1998, AIDS research and human retroviruses.

Human Immunodeficiency Virus (HIV)

J. Chermann, 1990 .

Anti-R7V antibodies as therapeutics for HIV-infected patients in failure of HAART.

J. Chermann, C. Haslin, 2002, Current opinion in biotechnology.

Prevalence of Antibodies to Lymphadenophahy‐AIDS Virus in French Haemophiliacs

J. Chermann, L. Montagnier, B. Legras, 1985, Vox sanguinis.

Differential HIV replication and HIV-induced interferon production in mononuclear phagocytes: relationship to cell maturation.

J. Chermann, V. Zachar, P. Ebbesen, 1991, Research in virology.

Lectin Effects on HIV‐1 Infectivity

J. Chermann, I. Hirsch, L. Hammar, 1994, Annals of the New York Academy of Sciences.

New bicyclam-AZT conjugates: design, synthesis, anti-HIV evaluation, and their interaction with CXCR-4 coreceptor.

J. Chermann, J. Kraus, P. Vlieghe, 1999, Journal of medicinal chemistry.

Binding of human immunodeficiency virus type-1 (HIV-1) to partially purified membrane vesicles of lymphoblastoid cell line CEM.

J. Chermann, I. Hirsch, A. B. Benzair, 1993, Journal of virological methods.

Use of monoclonal antibodies for the detection and quantitation of HIV1 core protein p25: comparative evaluation of in vitro HIV1 infection by immunofluorescence, antigen capture ELISA and reverse transcriptase assays.

J. Chermann, C. Devaux, M. Tatsumi, 1990, Research in virology.

Human T-lymphoblastoid cells selected for growth in serum-free medium provide new tools for study of HIV replication and cytopathogenicity.

J. Chermann, J. Fantini, S. Baghdiguian, 1991, Journal of virological methods.

[Infection of insect cell lines by the HIV virus, an agent of AIDS, and a demonstration of insects of African origin infected by this virus].

J. Chermann, F. Barré-Sinoussi, F. Rey, 1986, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

A novel epitope R7V common to all HIV-1 isolates is recognized by neutralizing IgG found in HIV-infected patients and immunized rabbits.

J. Chermann, C. le Contel, P. Galéa, 1999, Vaccine.

Immunonanoparticules coated with monoclonal anti-beta2 microglobulin antibodies and their use for the prophylaxis and / or treatment of pathologies due to infection with the HIV virus

J. Chermann, J. Teulon, F. Lescure, 1994 .

Tri-N-Boc-tetraazamacrocycle-nucleoside conjugates: synthesis and anti-HIV activities.

J. Chermann, J. Kraus, G. Quéléver, 1998, Nucleosides & nucleotides.

Synthesis and comparative anti-HIV activities of new acetylated 2′,3′-dideoxy-3′-thiacytidine analogues

J. Chermann, J. Kraus, M. Camplo, 1994 .

Tri‐N‐Boc‐tetraazamacrocycle—Nucleoside Conjugates: Synthesis and Anti‐HIV Activities.

J. Chermann, J. Kraus, G. Quéléver, 2010 .

POSSIBLE TRANSMISSION OF A HUMAN LYMPHOTROPIC RETROVIRUS (LAV) FROM MOTHER TO INFANT WITH AIDS

A. Fischer, V. Vié, F. Brun-Vézinet, 1984, The Lancet.

Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

J. Lifson, J. Chermann, S. West, 1985, Annals of internal medicine.

Characterization of HIV1-PAR, a macrophage-tropic strain: cell tropism, virus/cell entry and nucleotide sequence of the envelope glycoprotein.

J. Chermann, H. Schmidtmayerova, I. Hirsch, 1993, Research in virology.

IMMUNE STATUS OF AIDS PATIENTS IN FRANCE: RELATIONSHIP WITH LYMPHADENOPATHY ASSOCIATED VIRUS TROPISM a

J. Chermann, F. Barré-Sinoussi, W. Rozenbaum, 1984, Annals of the New York Academy of Sciences.

The gag precursor contains a specific HIV‐1 protease cleavage site between the NC (P7) and P1 proteins

J. Louis, B. Roques, J. Chermann, 1993, FEBS letters.

Powerful New Inhibitor of Murine Leukaemia and Sarcoma Viruses

J. Chermann, C. Jasmin, G. Mathé, 1970, Nature.

HIV1 cytopathogenicity-genetic difference between direct cytotoxic and fusogenic effect.

J. Chermann, I. Hirsch, D. Salaun, 1992, Virology.

Inhibition of tumour virus RNA-dependent DNA polymerase by the heteropolyan ion, silicotungstate.

J. Chermann, C. Jasmin, M. Raynaud, 1973, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Infection of HIV-1 and HIV-2 through the luminal and serosal sides of polarized human intestinal epithelial cells.

J. Chermann, J. Fantini, N. Yahi, 1992, AIDS.

Biosynthesis of LAV gag gene products: presence of an intracellular gag-pol precursor polyprotein

J. Chermann, F. Barré-Sinoussi, F. Rey, 1987 .

Evidence that membrane proteins of rhabdomyosarcoma cell line RD bind human immunodeficiency virus type 1 (HIV-1).

J. Chermann, I. Hirsch, A. B. Benzair, 1993, Cancer letters.

Experimental conditions that increase the production of HIV-1 by monocyte-derived macrophages: use of collagen matrix.

J. Chermann, C. Godard, 1999, Microbes and infection.

Differences in replication and cytopathogenicity of human immunodeficiency virus type 1 (HIV-1) are not determined by long terminal repeats (LTR).

J. Chermann, B. Spire, I. Hirsch, 1990, Virology.

Syntheses of new modified Phe-Pro peptides. Use of proline replacements in potential HIV inhibitors.

J. Chermann, J. Kraus, G. Quéléver, 1998, Bioorganic & medicinal chemistry letters.

Purification of Bacterial Endotoxins by Zonal Centrifugation

J. Chermann, M. Raynaud, M. Digeon, 1972, Infection and immunity.

TheHumanImmunodeficiency Virus(HIV) gag GeneProduct p18 IsResponsible forEnhancedFusogenicity andHostRange TropismoftheHighlyCytopathic HIV-1-NDKStrain

J. Chermann, I. Hirsch, B. Brichacek, 1992 .

TRANSMISSION EXPERIMENTS WITH HUMAN T-LYMPHOTROPIC RETROVIRUSES AND HUMAN AIDS TISSUE

J. Chermann, L. Montagnier, D. Gajdusek, 1984, The Lancet.

Purification of PO, Antigenic Subfraction of the Endotoxin Extracted from S. typhi O 901

J. Chermann, M. Raynaud, M. Navarro, 1975 .